Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HeLa-229 |
Human cervix adenocarcinoma cell line (derivat of HeLa) | Human | genital tract | cell line | adherent | plasmid | K2 Transfection System | publication | D. Kaul et al., Blood Cells, Molecules and Diseases, 2015, 55: 89-93, doi.org/10.1016/j.bcmd.2015.05.001 | ||||
HeLa-229 |
Human cervix adenocarcinoma cell line (derivat of HeLa) | Human | genital tract | cell line | adherent | plasmid | K2 Transfection System | publication | A. Garg et al., Blood Cells, Molecules and Diseases, 2015, 55: 248-254, doi.org/10.1016/j.bcmd.2015.07.009 | ||||
HeLa-ABCA1-GFP |
Human cervix adenocarcinoma cell line (derivat of HeLa) | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | N. Mukhamedova et al., Methods Mol. Biol., 2016 ; 1354: 281-292; doi:10.1007/978-1-4939-3046-3_19 | ||||
HeLa-DR-13–9 |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | B. Haynesa et al., Biochim Biophys Acta Mol Basis Dis., 2020,1866(1): 165561, doi:10.1016/j.bbadis | Link | ||
HeLa-S3 |
Human cervix carcinoma cell line (subclone) | ATCC CCL-2.2 | Human | genital tract | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
HeLa-T4 |
Human cervix carcinoma cell line susceptible to HIV-1 infection (Derivat of HeLa ) | Human | genital tract | cell line | suspension | plasmid | Metafectene | publication | D. Wilflingseder et al., J. Immunol., Jun 2007; 178: 7840 - 7848 | Link | |||
HOSE |
Human non-tumorigenic, immortalized ovarian epithelial cells | Human | genital tract | cell line | adherent | plasmid | Metafectene | application note | ![]() |
||||
KGN |
Human ovary granulosa-like tumor cell line | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | M. Lang-Muritano et al., J. of Clinical Endocrinology & Metabolism, 2018, 103(10): 3748–3756 | ||||
KGN |
Human ovary granulosa-like tumor cell line | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | L. Bouazzi et al., Scientific Reports, 2019, 9: 17033, doi.org/10.1038/s41598-019-53370-4 | Link | |||
KGN |
Human ovary granulosa-like tumor cell line | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | L. Bouazzi et al., J. Gyneco.l Reprod. Med., 2018, 2(1):1-9 | Link | |||
Lec1 |
Chinese hamster ovary cell line | ATCC CRL-1735 | Hamster | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A. Altamirano et al., J. Proteome Res., 2018, 17: 1269−1277, DOI:10.1021/acs.jproteome.7b00867 | ||
Lec2 |
Chinese hamster ovary cell line (derivat of CHO) | ATTC CRL 1736 | Hamster | genital tract | cell line | adherent | plasmid | Metafectene | publication | R. Kabuß et al., Glycobiology, Oct 2005; 15: 905 - 911 | Link | ||
Lec8 |
Chinese hamster ovary cell line (derivat of CHO) | ATCC CRL 1737 | Hamster | genital tract | cell line | adherent | plasmid | Metafectene | publication | R. Kabuß et al., Glycobiology, Oct 2005; 15: 905 - 911 | Link | ||
LNCaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | U. K. Mukhopadhyay et al., Cytokine, 2016; 82: 70-79; doi.org/10.1016/j.cyto.2016.01.013 | |||
LNCaP |
prostate epithelial cancer cells | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | M. Ansems et al., The Prostate, 2012, 72: 1708-1717, DOI 10.1002/pros.22522 | |||
LNcaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | G. Loubeau et al., PLoS ONE, 2014, 9(5): e96293, doi:10.1371/journal.pone.0096293 | Link | |
LNCaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | J. Elvenes et al., PLoS ONE, 2011, 6(9): e24659, doi:10.1371/journal.pone.0024659 | Link | |
LNCaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | Metafectene PRO | publication | J. J. Rodgers et al., J. Cell Biochem., 2019, 120:848-860, DOI: 10.1002/jcb.27446 | Link | ||
LNCaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | R. Malaguarnera et al., Endocrinology, 2014, 155(4): 1207-1221, doi: 10.1210/en.2013-1925 | Link | |
LNCaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | U. K. Mukhopadhyay et al., Cancer Res., Apr 2005; 65: 2872 - 2881 | Link | |
LNCaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | Metafectene PRO | publication | C. Morich, Dissertation, 2016, Georg-August University Göttingen | Link | ||
ME-180 |
Human papillomavirus-related cervical squamous cell carcinoma cell line | ATCC HTB-33 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | E. Xu et al., Mol. Cancer Res., 2014, 12(3):359-369, DOI: 10.1158/1541-7786.MCR-13-0526 | Link | ||
MSC-1 |
Murine sertoli cells | Murine | genital tract | unknown | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
NHF |
Human neonatal foreskin fibroblasts | Human | genital tract | unknown | adherent | plasmid | Metafectene PRO | publication | J. A. Eckers, Dissertation, 2013, University of Iowa | Link | |||
NHF |
Human neonatal foreskin fibroblasts | Human | genital tract | unknown | adherent | plasmid | Metafectene PRO | publication | J. C. Eckers et al., Int. J. Radiat. Oncol. Biol. Phys., 2013, 87(3): 619–625, doi:10.1016/j.ijrobp.2013.06.2063 | Link |